These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 30048255)
1. Recent insights into Shigella. Baker S; The HC Curr Opin Infect Dis; 2018 Oct; 31(5):449-454. PubMed ID: 30048255 [TBL] [Abstract][Full Text] [Related]
2. How can controlled human infection models accelerate clinical development and policy pathways for vaccines against Shigella? Giersing BK; Porter CK; Kotloff K; Neels P; Cravioto A; MacLennan CA Vaccine; 2019 Aug; 37(34):4778-4783. PubMed ID: 31358238 [TBL] [Abstract][Full Text] [Related]
3. A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology. von Seidlein L; Kim DR; Ali M; Lee H; Wang X; Thiem VD; Canh DG; Chaicumpa W; Agtini MD; Hossain A; Bhutta ZA; Mason C; Sethabutr O; Talukder K; Nair GB; Deen JL; Kotloff K; Clemens J PLoS Med; 2006 Sep; 3(9):e353. PubMed ID: 16968124 [TBL] [Abstract][Full Text] [Related]
4. Changing patterns of serotypes and antimicrobial susceptibilities of Shigella species isolated from children in Calcutta, India. Niyogi SK; Mitra U; Dutta P Jpn J Infect Dis; 2001 Jun; 54(3):121-2. PubMed ID: 11544405 [No Abstract] [Full Text] [Related]
5. The changing epidemiology of bacillary dysentery and characteristics of antimicrobial resistance of Shigella isolated in China from 2004-2014. Chang Z; Zhang J; Ran L; Sun J; Liu F; Luo L; Zeng L; Wang L; Li Z; Yu H; Liao Q BMC Infect Dis; 2016 Nov; 16(1):685. PubMed ID: 27863468 [TBL] [Abstract][Full Text] [Related]
6. Vaccines against Shigella and enterotoxigenic Escherichia coli: A summary of the 2016 VASE Conference. Walker RI; Wierzba TF; Mani S; Bourgeois AL Vaccine; 2017 Dec; 35(49 Pt A):6775-6782. PubMed ID: 28987444 [TBL] [Abstract][Full Text] [Related]
8. Global burden of diarrheal diseases among children in developing countries: Incidence, etiology, and insights from new molecular diagnostic techniques. Kotloff KL; Platts-Mills JA; Nasrin D; Roose A; Blackwelder WC; Levine MM Vaccine; 2017 Dec; 35(49 Pt A):6783-6789. PubMed ID: 28765005 [TBL] [Abstract][Full Text] [Related]
9. Epidemiology and clinical presentation of shigellosis in children less than five years of age in rural Mozambique. Mandomando I; Sigaúque B; Vallès X; Espasa M; Sanz S; Sacarlal J; Macete E; Abacassamo F; Ruiz J; Gascon J; Kotloff KL; Levine MM; Alonso PL Pediatr Infect Dis J; 2007 Nov; 26(11):1059-61. PubMed ID: 17984817 [TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility pattern, and associated factors of Salmonella and Shigella infections among under five children in Arba Minch, South Ethiopia. Ameya G; Tsalla T; Getu F; Getu E Ann Clin Microbiol Antimicrob; 2018 Feb; 17(1):1. PubMed ID: 29391040 [TBL] [Abstract][Full Text] [Related]
11. [Pathogenic surveillance and related factors on bacillary dysentery in Beijing, 2008-2017]. Jia L; Lyu B; Tian Y; Zhang X; Liu ZC; Peng H; Li HJ; Zhen BJ; Wang XL; Huang Y; Qu M; Wang QY Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Feb; 40(2):165-169. PubMed ID: 30744266 [No Abstract] [Full Text] [Related]
12. A comparison of disease caused by Shigella and Campylobacter species: 24 months community based surveillance in 4 slums of Karachi, Pakistan. Soofi SB; Habib MA; von Seidlein L; Khan MJ; Muhammad S; Bhutto N; Khan MI; Rasool S; Zafar A; Clemens JD; Nizami Q; Bhutta ZA J Infect Public Health; 2011 Mar; 4(1):12-21. PubMed ID: 21338955 [TBL] [Abstract][Full Text] [Related]
13. Subtype prevalence, plasmid profiles and growing fluoroquinolone resistance in Shigella from Kolkata, India (2001-2007): a hospital-based study. Nandy S; Mitra U; Rajendran K; Dutta P; Dutta S Trop Med Int Health; 2010 Dec; 15(12):1499-507. PubMed ID: 20955371 [TBL] [Abstract][Full Text] [Related]
14. Editorial commentary: a Shigella vaccine against prevalent serotypes. Van de Verg LL; Venkatesan MM Clin Infect Dis; 2014 Oct; 59(7):942-3. PubMed ID: 24958237 [No Abstract] [Full Text] [Related]
15. Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road. Levine MM; Kotloff KL; Barry EM; Pasetti MF; Sztein MB Nat Rev Microbiol; 2007 Jul; 5(7):540-53. PubMed ID: 17558427 [TBL] [Abstract][Full Text] [Related]
16. Multiresistant Shigella species isolated from childhood diarrhea cases in Kolkata, India. Niyogi SK; Pazhani GP Jpn J Infect Dis; 2003 Feb; 56(1):33-4. PubMed ID: 12711826 [No Abstract] [Full Text] [Related]
17. Using advocacy to increase investment in enteric vaccine development. Randall H; Kallen LE Vaccine; 2019 Aug; 37(34):4811-4813. PubMed ID: 30737042 [TBL] [Abstract][Full Text] [Related]
18. [Analysis of 1185 strains of Shigella isolated in Mexico from 1982 to 1993]. Gutiérrez-Cogco L; González-Bonilla C; Figueroa-Arredondo P Rev Latinoam Microbiol; 1994; 36(4):227-30. PubMed ID: 7701131 [TBL] [Abstract][Full Text] [Related]